Item 8.01 Other Events.

On October 12, 2021, Inspyr Therapeutics, Inc., (the "Company"), announced the completion of (i) the 1-for-75 reverse stock split as previously disclosed, and (ii) its reorganization into a holding company structure changing its corporate name. At the market open on October 12, 2021, the Company will begin trading on a post-split basis as Rebus Holdings, Inc. under the symbol RBSH. The new CUSIP is 75619J 103. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.01.

Item 9.01 Financial Statement and Exhibits.






Exhibit
No.                      Description
99.01       Press Release dated October 12, 2021.




                                       1

© Edgar Online, source Glimpses